CordovaCann (LVRLF) Cash from Financing Activities (2013 - 2020)
CordovaCann (LVRLF) recorded quarterly Cash from Financing Activities of $525042.2 in Q2 2020, up 16.35% quarter-over-quarter from $451274.4 in Q1 2020, and down 69.05% on a YoY basis from $1.7 million in Q3 2019.
CordovaCann (LVRLF) Cash from Financing Activities (2013 - 2020) Analysis & Trends
CordovaCann's Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $525042.2 for Q2 2020.
- In Q2 2020, Cash from Financing Activities fell 69.05% year-over-year to $525042.2; the TTM figure through Jun 2020 stood at $1.2 million (down 80.84% YoY), while the FY2025 annual figure was -$1.8 million, down 122.35% from the prior year.
- Cash from Financing Activities was $525042.2 for Q2 2020 at CordovaCann, up from $451274.4 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $3.4 million in Q2 2018 to a low of -$78445.6 in Q2 2016.
- Historically, Cash from Financing Activities has averaged $547716.4 across 5 years, with a median of $203653.3 in 2017.
- The sharpest annual moves came in 2016 and 2018: Cash from Financing Activities tumbled 90.73% in 2016, then surged 436888.14% in 2018.
- A 5-year view of Cash from Financing Activities shows it stood at $1042.5 in 2016, then jumped by 24352.55% to $254920.0 in 2017, then soared by 1252.66% to $3.4 million in 2018, then slumped by 95.58% to $152386.7 in 2019, then surged by 244.55% to $525042.2 in 2020.
- The last three Cash from Financing Activities figures came in at $525042.2 (Q2 2020), $451274.4 (Q1 2020), and $152386.7 (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | CordovaCann | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 525,042.24 |
| Jun 30, 2020 | 525,042.24 |
| Mar 31, 2020 | 451,274.43 |
| Mar 31, 2020 | 451,274.43 |
| Dec 31, 2019 | 152,386.70 |
| Dec 31, 2019 | 152,386.70 |
| Sep 30, 2019 | 74,590.79 |
| Sep 30, 2019 | 74,590.79 |
| Jun 30, 2019 | 1.70 Mn |
| Jun 30, 2019 | 1.70 Mn |
| Mar 31, 2019 | 376,389.24 |
| Mar 31, 2019 | 376,389.24 |
| Jun 30, 2018 | 3.45 Mn |
| Jun 30, 2018 | 3.45 Mn |
| Mar 31, 2018 | 758,962.55 |
| Mar 31, 2018 | 758,962.55 |
| Dec 31, 2017 | 254,919.95 |
| Dec 31, 2017 | 254,919.95 |
| Sep 30, 2017 | 334.11 |
| Sep 30, 2017 | 334.11 |